Jingyue Ju, PhD, Samuel Ruben-Peter G. Viele Professor of Engineering, Professor of Chemical Engineering and Pharmacology, Director, Center for Genome Technology and Biomolecular Engineering, Columbia University, "Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19"
Dr. Ju in his talk presented in detail the CoV-2 Polymerase cycle, which step-wise replicates the virus RNA. The Polymerase is a very well defined drug target, favourable for possible vaccines. This is very similar to the Hepatitis C virus and indeed drugs developed for this virus showed promising results as a possible treatment of COVID-19.
